Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4397222

Review assay metadata, readout intent, target linkage, and publication context from the same page.

ADMET
Inhibition of CYPC19 (unknown origin) by fluorescence-based assay
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type ADMET
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Cytochrome P450 2C19 (CHEMBL3622)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.
Gurney ME, Nugent RA, Mo X, Sindac JA, Hagen TJ, Fox D, O'Donnell JM, Zhang C, Xu Y, Zhang HT, Groppi VE, Bailie M, White RE, Romero DL, Vellekoop AS, Walker JR, Surman MD, Zhu L, Campbell RF.
J Med Chem (2019) 62 : 4884 -4901
PubMed 31013090 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 2 4.46 4.54

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4573171 1 4.54
CHEMBL4541964 ZATOLMILAST 3.0 1 4.37

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4573171 IC50 = 29000.0 nM 4.54
CHEMBL4541964 ZATOLMILAST IC50 = 43000.0 nM 4.37